USD 138.90 bn growth in Generic Drugs Market from 2021 to 2025|Technavio

NEW YORK, Oct. 8, 2021 /PRNewswire/ --

Technavio has announced its latest market research report titled Generic Drugs Market by Type and Geography - Forecast and Analysis 2021-2025

The generic drugs market is set to grow by USD 138.90 billion from 2021 to 2025, progressing at a CAGR of  6.33%. The generic drugs market analysis includes type and geography landscape. This report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters

Read our Free Sample Report to make the most of future growth opportunities.

The generic drugs market report offers a comprehensive analysis of the strategies adopted by vendors and the trends, drivers, and challenges affecting the market size. The report identifies low-cost alternatives as one of the major factors driving the growth of the market. The advent of RPA, rising M&A, and hospital-owned generics will be some of the trends in the market during the next few years.

The generic drugs market covers the following areas:

Generic Drugs Market Sizing
Generic Drugs Market Forecast
Generic Drugs Market Analysis

Companies Mentioned

  • Amgen Inc.
  • Dr. Reddys Laboratories Ltd.
  • Fresenius SE and Co. KGaA
  • Merck and Co. Inc.
  • Novartis AG
  • Pfizer Inc.
  • Sanofi SA
  • Sun Pharmaceutical Industries Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • Viatris Inc.

Subscribe to our "Lite Plan" billed annually at USD 3000 to view 3 reports monthly and download 3 reports annually.

Related Reports:

  • Lung Cancer Therapeutics Market by Type and Geography - Forecast and Analysis 2021-2025: The lung cancer therapeutics market has the potential to grow by USD 6.79 billion from 2021 to 2025. Download Exclusive Free Sample Report
  • Interstitial Cystitis Drugs Market by Type and Geography - Forecast and Analysis 2021-2025: The interstitial cystitis drugs market has the potential to grow by USD 283.95 million from 2021 to 2025. Download Free Sample Report

Generic Drugs Market Scope

Report Coverage


Page number


Base year


Forecast period


Growth momentum & CAGR

Accelerate at a CAGR of 6.33%

Market growth 2021-2025

$ 138.90 billion

Market structure


YoY growth (%)


Regional analysis

North America, Europe, Asia, and ROW

Performing market contribution

North America at 39%

Key consumer countries

US, Germany, China, Japan, and UK

Competitive landscape

Leading companies, competitive strategies, consumer engagement scope

Companies profiled

Amgen Inc., Dr. Reddys Laboratories Ltd., Fresenius SE and Co. KGaA, Merck and Co. Inc., Novartis AG, Pfizer Inc., Sanofi SA, Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., and Viatris Inc.

Market Dynamics

Parent market analysis, market growth inducers and obstacles, fast-growing and slow-growing segment analysis, COVID 19 impact and future consumer dynamics, market condition analysis for forecast period,

Customization purview

If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

About Us
Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200

Technavio (PRNewsfoto/Technavio)

Cision View original content to download multimedia:

SOURCE Technavio

News, commentary and research reports are from third-party sources unaffiliated with Fidelity. Fidelity does not endorse or adopt their content. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use.